Rationale for Phase III PROSPECT Trial in Prostate Cancer

Dr. Shore on the Rationale for the Phase 3 HERO Trial in Advanced Prostate CancerПодробнее

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancerПодробнее

ESMO 2016: Press brief on the AFFINITY Phase III trial for second-line metastatic prostate cancerПодробнее

Results of 5 year phase III randomised trial treating localised prostate cancerПодробнее

Timing of ADT and ChemotherapyПодробнее

Phase III trial of the impact of PSMA PET/CT in salvage radiotherapy managementПодробнее

HERO phase III trial in advanced prostate cancerПодробнее

Rationale of Phase III PCS5 trial of hypofractionated radiotherapy for prostate cancerПодробнее

Results of the Phase III PCS5 trial of hypofractionated radiotherapy for prostate cancerПодробнее

Expert Video Viewpoints on Castration-Resistant Prostate Cancer - Section 3Подробнее

Evaluating Significance of ENZAMET Trial in Metastatic Hormone-Sensitive Prostate CancerПодробнее

CLARIFY: Phase 3 Diagnostic Trial of 64Cu-SAR-bisPSMA PET Imaging in Prostate Cancer Before SurgeryПодробнее

ImmunoTherapy - Prostvac phase III Clinical Study for advanced Prostate CancerПодробнее

Current perspectives from clinical trials using PARP inhibitors for prostate cancerПодробнее

Prostate Cancer Clinical Trial: ESCAPE TrialПодробнее

Dr. Vogelzang Discusses PROSPECT Trial for Prostate CancerПодробнее

Significance of a Phase III Study on Docetaxel With Hormonal & Radiation Therapy in Prostate CancerПодробнее

Phase 3 trial results suggest potential new treatment approach for prostate cancerПодробнее

PROSPECT: how effective is the new prostvac vaccine against prostate cancer?Подробнее